Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.84 USD | -6.56% | -7.74% | -25.03% |
Mar. 27 | Health Care Jumps as Upward Momentum Builds -- Health Care Roundup | DJ |
Mar. 27 | Transcript : Syros Pharmaceuticals, Inc., 2023 Earnings Call, Mar 27, 2024 |
Financials (USD)
Sales 2024 * | 6.33M | Sales 2025 * | 82.42M | Capitalization | 152M |
---|---|---|---|---|---|
Net income 2024 * | -122M | Net income 2025 * | -112M | EV / Sales 2024 * | 14.8 x |
Net cash position 2024 * | 58.22M | Net cash position 2025 * | - | EV / Sales 2025 * | 1.84 x |
P/E ratio 2024 * |
-1.77
x | P/E ratio 2025 * |
-1.75
x | Employees | 117 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99% |
Latest transcript on Syros Pharmaceuticals, Inc.
1 day | -6.56% | ||
1 week | -7.74% | ||
Current month | -19.56% | ||
1 month | -20.44% | ||
3 months | -20.11% | ||
6 months | +46.73% | ||
Current year | -25.03% |
Managers | Title | Age | Since |
---|---|---|---|
Conley Chee
CEO | Chief Executive Officer | 54 | 21-09-26 |
Jason Haas
DFI | Director of Finance/CFO | 56 | 21-10-11 |
David Roth
CTO | Chief Tech/Sci/R&D Officer | 61 | 15-12-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Srini Akkaraju
BRD | Director/Board Member | 56 | 17-06-11 |
Tim Tyson
BRD | Director/Board Member | 71 | 22-09-15 |
Marsha Fanucci
BRD | Director/Board Member | 70 | 15-10-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 5.84 | -6.56% | 431,796 |
24-03-26 | 6.25 | -2.34% | 108,950 |
24-03-25 | 6.4 | +2.07% | 156,038 |
24-03-22 | 6.27 | -1.10% | 62,303 |
24-03-21 | 6.34 | +0.16% | 107,080 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.03% | 152M | |
+9.16% | 45.97B | |
+54.09% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |